U.S. DoJ will not challenge Aetna-CVS deal – report

FAN Editor
A CVS Pharmacy store is seen in the Manhattan borough of New York City
A CVS Pharmacy store is seen in the Manhattan borough of New York City, New York, U.S., November 30, 2017. REUTERS/Shannon Stapleton

July 12, 2018

(Reuters) – Shares of CVS Health Corp <CVS.N> and health insurer Aetna Inc <AET.N> rose more than 2 percent on Thursday after CNBC reported that the U.S. Justice Department will not challenge their planned merger.

CNBC said https://www.cnbc.com/2018/07/12/cvs-aetna-shares-rise-on-report-doj-wont-challenge-their-merger-deal.html Bloomberg reported the news, citing trade publication Reorg Research.

CVS Health Corp and Aetna announced the $69 billion deal on Dec. 3 last year, arguing it would enable the companies to tackle soaring healthcare spending by offering lower-cost medical services in pharmacies.

Aetna and CVS declined to comment.

(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)

Free America Network Articles

Leave a Reply

Next Post

Should You Cozy Up to Consumer Cyclical ETFs?

This article was originally published on ETFTrends.com. The Consumer Discretionary Select Sector SPDR (NYSEArca: XLY), the largest exchange traded fund tracking the consumer discretionary, and rival consumer cyclical funds are delivering for investors this year. XLY is higher by 13% year-to-date and some market observers see more upside for the […]

You May Like